IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

256
IARC MONOGRAPHS VOLUME 82
Gallagher, E.P., Kunze, K.L., Stapleton, P.L. & Eaton, D.L. (1996) The kinetics of aflatoxin B 1
oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2
and 3A4. Toxicol. appl. Pharmacol., 141, 595–606
Galvano, F., Galofaro, V. & Galvano, G. (1996) Occurrence and stability of aflatoxin M 1 in milk
and milk products: A worldwide review. J. Food Protect., 59, 1079–1090
Geiser, D.M., Pitt, J.I. & Taylor, J.W. (1998) Cryptic speciation and recombination in the
aflatoxin-producing fungus Aspergillus flavus. Proc. natl Acad. Sci. USA, 95, 388–393
Geiser, D.M., Dorner, J.W., Horn, B.W. & Taylor, J.W. (2000) The phylogenetics of mycotoxin
and sclerotium production in Aspergillus flavus and Aspergillus oryzae. Fungal Genet. Biol.,
31, 169–179
Ghebranious, N. & Sell, S. (1998a) Hepatitis B injury, male gender, aflatoxin, and p53 expression
each contribute to hepatocarcinogenesis in transgenic mice. Hepatology, 27, 383–391
Ghebranious, N. & Sell, S. (1998b) The mouse equivalent of the human p53ser246 mutation
p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic
and p53 heterozygous null mice. Hepatology, 27, 967–973
Ghosh, S.K., Desai, M.R., Pandya, G.L. & Venkaiah, K. (1997) Airborne aflatoxin in the grain
processing industries in India. Am. ind. Hyg. Assoc. J., 58, 583–586
Goeger, D.E., Anderson, K.E. & Hsie, A.W. (1998) Coumarin chemoprotection against aflatoxin
B 1-induced gene mutation in a mammalian cell system: A species difference in mutagen activation
and protection with chick embryo and rat liver S9. Environ. mol. Mutag., 32, 64–74
Goeger, D.E., Hsie, A.W. & Anderson, K.E. (1999) Co-mutagenicity of coumarin (1,2-benzopyrone)
with aflatoxin B 1 and human liver S9 in mammalian cells. Food chem. Toxicol., 37,
581–589
Gong, Y.Y., Cardwell, K., Hounsa, A., Egal, S., Turner, P.C., Hall, A.J. & Wild, C.P. (2002)
Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo:
Cross-sectional study. Br. med. J., 325, 20–21
González, H.H.L., Martínez, E.J., Pacin, A.M., Resnik, S.L. & Sydenham, E.W. (1999) Natural
co-occurrence of fumonisins, deoxynivalenol, zearalenone and aflatoxins in field trial corn in
Argentina. Food Addit. Contam., 16, 565–569
Gopalakrishnan, S., Harris, T.M. & Stone, M.P. (1990) Intercalation of aflatoxin B 1 in two oligodeoxynucleotide
adducts: Comparative 1 H NMR analysis of d(ATC AFB GAT).d(ATCGAT) and
d(AT AFB GCAT) 2. Biochemistry, 29, 10438–10448
Gopalan, P., Tsuji, K., Lehmann, K., Kimura, M., Shinozuka, H., Sato, K. & Lotlikar, P.D. (1993)
Modulation of aflatoxin B 1-induced glutathione S-transferase placental form positive hepatic
foci by pretreatment of rats with phenobarbital and buthionine sulfoximine. Carcinogenesis,
14, 1469–1470
Gorelick, N.J. (1990) Risk assessment for aflatoxin: I. Metabolism of aflatoxin B 1 by different
species. Risk Anal., 10, 539–559
Goto, T., Wicklow, D.T. & Ito, Y. (1996) Aflatoxin and cyclopiazonic acid production by a sclerotium-producing
Aspergillus tamarii strain. Appl. environ. Microbiol., 62, 4036–4038
Groopman, J.D. (1993) Molecular dosimetry methods for assessing human aflatoxin exposures.
In: Eaton, D.L. & Groopman, J.D., eds, The Toxicology of Aflatoxins: Human Health, Veterinary
and Agricultural Significance, New York, Academic Press, pp. 259–279
Groopman, J.D. & Kensler, T.W. (1999) The light at the end of the tunnel for chemical-specific
biomarkers: Daylight or headlight? Carcinogenesis, 20, 1–11